Search Results - lin+chang

2 Results

Sort By:

DNA Methylation-Based Algorithm to Diagnose Irritable Bowel Syndrome and Other GI Conditions (UCLA Case No. 2022-229)

UCLA researchers in the Department of Gastroenterology have developed a DNA methylation-based algorithm to diagnose irritable bowel syndrome and other GI conditions. Blood-based genome-wide DNA methylation profiles have been utilized to develop a reliable test to diagnose irritable bowel syndrome (IBS) versus inflammatory bowel disease (IBD), celiac...

Published: 9/11/2025 | Inventor(s): Lin Chang, Swapna Joshi

Keywords(s):

Category(s): Therapeutics > Gastroenterology, Platforms > Diagnostic Platform Technologies

Epigenetic Profile-Based Biomarkers for Irritable Bowel Syndrome (UCLA Case No. 2018-578)

SummaryUCLA researchers from the Vatche and Tamar Manoukian Division of Digestive Diseases have discovered an innovative approach to diagnose irritable bowel syndrome. This method uses a set of epigenetic profiles as biomarkers and is highly sensitive compared to conventional diagnostic methodologies. BackgroundIrritable bowel syndrome (IBS) affects...

Published: 7/17/2025 | Inventor(s): Lin Chang, Swapnali Joshi

Keywords(s): Diagnostic Markers & Platforms, Diagnostic Platform Technologies (E.G. Microfluidics), Gastroenterology & Digestive Disease

Category(s): Diagnostic Markers, Platforms > Diagnostic Platform Technologies, Therapeutics > Gastroenterology